No Detail Found!

Immunomodulatory potential of melatonin in immunosuppression: an in-vivo study

Author(s)
Aamina Quddus Qureshi Department of Physiology, CMH Lahore Medical College and Institute of Dentistry, NUMS,Lahore,Pakistan; Department of Basic Health Sciences, NUR International University,Lahore,Pakistan
Saghir Ahmed Jafri Department of Basic Health Sciences, NUR International University,Lahore,Pakistan
Ambreen Tauseef Department of Physiology, CMH Lahore Medical College and Institute of Dentistry, NUMS,Lahore,Pakistan
Waqar Ahmed Siddiqui Department of Pharmacology, CMH Lahore Medical College and Institute of Dentistry, NUMS,Lahore,Pakistan
Amna Irum Department of Basic Health Sciences, NUR International University,Lahore,Pakistan
Ayela Eman Zia Department of Pharmacology, CMH Lahore Medical College and Institute of Dentistry, NUMS,Lahore,Pakistan
Abstract
Objective: To assess the immunomodulatory e ects of melatonin on the acquired immunity of immunosuppressed male Wistar rats by checking Interleukin 6 (IL-6) levels, total leucocyte counts (TLC), and di erential leucocyte counts. Study Design: Experimental study. Place and Duration of the Study: Animal laboratory, CMH Lahore Medical College, from June to October 2023. Methodology: Fifty male Wistar rats, weighing 180g to 200g, were included in this study with 10 rats in each of the ve groups namely cyclophosphamide (CP), CP + melatonin, CP + immunomodulator, melatonin-only, and control. A calculated dose of CP was administered intraperitoneally for 30 days (from 13/06/23 to 13/07/23) to each group except the control groups. After this, the experimental group was given melatonin CP + Melatonin for 7 days (from 14/07/23 to 20/07/23). CP + Immunomodulatory group was kept for comparison of immunomodulatory e ects. Blood samples were drawn from all 5 groups. IL-6 was estimated through ELISA. Other parameters assessed were TLC and absolute di erential leucocyte counts. Results: Melatonin increased IL-6 levels signi cantly (p = 0.042) as well as the TLC levels (p <0.001) compared to the immunosuppressed CP group. Melatonin was seen to have an upregulation of IL-6 levels in immunosuppression compared to the administration of immunomodulator preparation (p = 0.506) which was not as e ective. Administration of melatonin signi cantly increased the TLC, neutrophil, lymphocyte, monocyte, and eosinophil count compared to known immunomodulators. Conclusion: Melatonin as a supplement may have some role in activating multiple immune response processes in immunedepressed states. It was also established that it allows quick recovery of cell components from immunosuppressed states.
Publication Details
Page(s) 1270-1274
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 11, Year: 2024

Request the full text from PASTIC

Keywords
Cyclophosphamide, Immunomodulation, Interleukin-6, Melatonin, Rats, Acquired immunity
0

Citations

0

Downloads

68

Views